Venous Thromboembolism: Current Insights and Future Directions

Abstract

Venous thromboembolism (VTE) is the third most common cause of death worldwide even though incidence rates differ globally. Western nations report 1 to 2 cases per 1,000 person-years, while Eastern countries exhibit lower rates (<1 per 1,000 person-years). This comprehensive review delves into diverse VTE risk factors including gender, diabetes, obesity, smoking, genetic mutations, hormonal influences, travel, infections, trauma, and cancer. Notably, VTE incidence is highest in certain cancers (such as pancreatic, liver, and non-small-cell lung cancers) and lowest in others (such as breast, melanoma, and prostate cancers). The extensive review provides essential information about prevalent factors and explores potential molecular mechanism contributing to VTE.

Keywords

deep venous thrombosis - pulmonary embolism - pulmonary hypertension - thromboembolic disease - anticoagulation - thrombolytic - right heart strain - cancer

Publikationsverlauf

Artikel online veröffentlicht:
08. Juli 2024

• References

• 1 Pastori D, Cormaci VM, Marucci S. et al. A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci 2023; 24 (04) 3169
• 2 Anderson Jr FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 (23, suppl 1): I9-I16
• 3 Tak T, Karturi S, Sharma U, Eckstein L, Poterucha JT, Sandoval Y. Acute pulmonary embolism: contemporary approach to diagnosis, risk-stratification, and management. Int J Angiol 2019; 28 (02) 100-111
• 4 Lehnert P, Lange T, Møller CH, Olsen PS, Carlsen J. Acute pulmonary embolism in a National Danish Cohort: increasing incidence and decreasing mortality. Thromb Haemost 2018; 118 (03) 539-546
• 5 Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med 2010; 38 (4, suppl): S502-S509
• 6 Shah IK, Merfeld JM, Chun J, Tak T. Pathophysiology and management of pulmonary embolism. Int J Angiol 2022; 31 (03) 143-149
• 7 Cohen AT, Agnelli G, Anderson FA. et al; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98 (04) 756-764
• 8 Konstantinides SV, Meyer G, Becattini C. et al; The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 54 (03) 1901647
• 9 Anderson Jr FA, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007; 82 (09) 777-782
• 10 Baglin T. Inherited and acquired risk factors for venous thromboembolism. Semin Respir Crit Care Med 2012; 33 (02) 127-137
• 11 Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007; 44 (02) 62-69
• 12 Andrews RK, López JA, Berndt MC. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997; 29 (01) 91-105
• 13 Tomaiuolo M, Brass LF, Stalker TJ. Regulation of platelet activation and coagulation and its role in vascular injury and arterial thrombosis. Interv Cardiol Clin 2017; 6 (01) 1-12
• 14 Sarratt KL, Chen H, Zutter MM, Santoro SA, Hammer DA, Kahn ML. GPVI and α2β1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood 2005; 106 (04) 1268-1277
• 15 Smith SA, Travers RJ, Morrissey JH. How it all starts: initiation of the clotting cascade. Crit Rev Biochem Mol Biol 2015; 50 (04) 326-336
• 16 Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 2013; 18 (02) 129-138
• 17 Lyhne MD, Kline JA, Nielsen-Kudsk JE, Andersen A. Pulmonary vasodilation in acute pulmonary embolism - a systematic review. Pulm Circ 2020; 10 (01) 2045894019899775
• 18 Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM. Epidemiology, pathophysiology, and natural history of pulmonary embolism. Semin Intervent Radiol 2018; 35 (02) 92-98
• 19 Ebner M, Eckelt J, Hobohm L. et al. Causes of death and predictors of long-term mortality after pulmonary embolism. Eur Heart J 2022; 43 (02) 544
• 20 Klok FA, van Kralingen KW, van Dijk APJ. et al. Quality of life in long-term survivors of acute pulmonary embolism. Chest 2010; 138 (06) 1432-1440
• 21 Bryce YC, Perez-Johnston R, Bryce EB, Homayoon B, Santos-Martin EG. Pathophysiology of right ventricular failure in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: a pictorial essay for the interventional radiologist. Insights Imaging 2019; 10 (01) 18
• 22 Lapostolle F, Surget V, Borron SW. et al. Severe pulmonary embolism associated with air travel. N Engl J Med 2001; 345 (11) 779-783
• 23 Kahn SR. The clinical diagnosis of deep venous thrombosis: integrating incidence, risk factors, and symptoms and signs. Arch Intern Med 1998; 158 (21) 2315-2323
• 24 de Wit K, D'Arsigny CL. Risk stratification of acute pulmonary embolism. J Thromb Haemost 2023; 21 (11) 3016-3023
• 25 Morrone D, Morrone V. Acute pulmonary embolism: focus on the clinical picture. Korean Circ J 2018; 48 (05) 365-381
• 26 Kearon C. Diagnosis of suspected venous thromboembolism. Hematology (Am Soc Hematol Educ Program) 2016; 2016 (01) 397-403
• 27 Karande GY, Hedgire SS, Sanchez Y. et al. Advanced imaging in acute and chronic deep vein thrombosis. Cardiovasc Diagn Ther 2016; 6 (06) 493-507
• 28 Theerakulpisut D, Wongsurawat N, Somboonporn C. Detection of lower limb deep vein thrombosis: comparison between radionuclide venography and venous ultrasonography. World J Nucl Med 2018; 17 (01) 27-33
• 29 Oh JK, Park JH. Role of echocardiography in acute pulmonary embolism. Korean J Intern Med (Korean Assoc Intern Med) 2023; 38 (04) 456-470
• 30 Mirza H, Hashmi MF. Lung Ventilation Perfusion Scan (VQ Scan). Treasure Island, FL: StatPearls Publishing; 2024
• 31 Torbicki A, Perrier A, Konstantinides S. et al; ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29 (18) 2276-2315
• 32 Galanaud JP, Laroche JP, Righini M. The history and historical treatments of deep vein thrombosis. J Thromb Haemost 2013; 11 (03) 402-411
• 33 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162) 1386-1389
• 34 Chen J, Castle JC, Makary MS, Yang X, Dowell JD. Greenfield stainless steel vena cava filters on computed tomography follow-up. J Vasc Surg Venous Lymphat Disord 2020; 8 (05) 762-768
• 35 DeYoung E, Minocha J. Inferior vena cava filters: guidelines, best practice, and expanding indications. Semin Intervent Radiol 2016; 33 (02) 65-70
• 36 Mellado M, Pijoan JI, Jiménez D. et al; RIETE Investigators. Outcomes associated with inferior vena cava filters among patients with thromboembolic recurrence during anticoagulant therapy. JACC Cardiovasc Interv 2016; 9 (23) 2440-2448
• 37 Patel SH, Patel R. Inferior vena cava filters for recurrent thrombosis: current evidence. Tex Heart Inst J 2007; 34 (02) 187-194
• 38 Remillard TC, Kassam Z, Coven M, Mangla A, Lasic Z. Pulmonary embolism complicated with cardiopulmonary arrest treated with combination of thrombolytics and aspiration thrombectomy. JACC Case Rep 2022; 4 (10) 576-580
• 39 Stevens SM, Woller SC, Bauer KA. et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis 2016; 41 (01) 154-164
• 40 Konstantinides SV, Vicaut E, Danays T. et al. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol 2017; 69 (12) 1536-1544
• 41 Ucar EY. Update on thrombolytic therapy in acute pulmonary thromboembolism. Eurasian J Med 2019; 51 (02) 186-190
• 42 Becattini C, Agnelli G, Lankeit M. et al. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J 2016; 48 (03) 780-786
• 43 Chen A, Stecker E. A Warden B. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc 2020; 9 (13) e017559
• 44 Frank C, Ratchford EV, Moll S. Vascular disease patient information page: a guide for patients with newly diagnosed deep vein thrombosis or pulmonary embolism. Vasc Med 2023; 28 (05) 481-486
• 45 Bhalla A, Attaran R. Mechanical circulatory support to treat pulmonary embolism: venoarterial extracorporeal membrane oxygenation and right ventricular assist devices. Tex Heart Inst J 2020; 47 (03) 202-206
• 46 Elder M, Blank N, Kaki A. et al. Mechanical circulatory support for acute right ventricular failure in the setting of pulmonary embolism. J Interv Cardiol 2018; 31 (04) 518-524
• 47 Girdhar G, Xenos M, Alemu Y. et al. Device thrombogenicity emulation: a novel method for optimizing mechanical circulatory support device thromboresistance. PLoS One 2012; 7 (03) e32463
• 48 Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg 2011; 6: 147
• 49 Wan YD, Sun TW, Kan QC, Guan FX, Liu ZQ, Zhang SG. The effects of intra-aortic balloon pumps on mortality in patients undergoing high-risk coronary revascularization: a meta-analysis of randomized controlled trials of coronary artery bypass grafting and stenting era. PLoS One 2016; 11 (01) e0147291
• 50 Botti G, Gramegna M, Burzotta F. et al; IMP IT Investigators. Impella RP for patients with acute right ventricular failure and cardiogenic shock: a subanalysis from the IMP-IT Registry. J Pers Med 2022; 12 (09) 1481
• 51 Vanden Eynden F, Mets G, De Somer F, Bouchez S, Bove T. Is there a place for intra-aortic balloon counterpulsation support in acute right ventricular failure by pressure-overload?. Int J Cardiol 2015; 197: 227-234
• 52 Winter MP, Schernthaner GH, Lang IM. Chronic complications of venous thromboembolism. J Thromb Haemost 2017; 15 (08) 1531-1540
• 53 Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 2005; 3 (08) 1611-1617